KIT and colorectal carcinoma: Compared with CRC, after intervention with ZS40-H, ZS40-L, BLA, and SD, the positive expression rate decreased (AOD: CD34 ZS40-H: 0.335 ± 0.05, ZS40-L: 0.398 ± 0.01, BLA: 0.349 ± 0.01, SD: 0.376 ± 0.01; CD117 ZS40-H: 0.367 ± 0.01, ZS40-L: 0.392 ± 0.04, BLA: 0.389 ± 0.01, SD: 0.369 ± 0.01).